Merit Medical Introduces BackStop(R)Plus Safety Device
Merit Medical Systems Inc. (Nasdaq: MMSI), a leading manufacturer and marketer of proprietary disposable accessories used primarily in cardiology and radiology procedures, announced full market release of its new, patented BackStop(R)Plus safety device today.
The BackStop(R)+ combines a closed waste disposal basin and temporary sharps holder in one convenient safety product, which helps protect health care workers from exposure to blood-borne pathogens and needle-related injuries. It is the third of seven new Merit products scheduled for release by the end of the year and is being introduced along with the MiniStop(TM)Plus, another patented safety product.
“Merit is committed to creating safer conditions for clinicians and patients,” said Fred P. Lampropoulos, Merit’s chairman and chief executive officer. “We have become the leader in cardiology and radiology safety products, and the BackStop(R)+ is an extension of this growing line.”
About Merit
Founded in 1987, Merit Medical Systems Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical accessories used in interventional and diagnostic procedures, particularly in cardiology and radiology. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 70 individuals. Merit employs approximately 1,480 people worldwide, with manufacturing facilities in Salt Lake City and South Jordan, Utah; Santa Clara, Calif.; Angleton, Texas; Richmond, Va.; Maastricht, Netherlands; and Galway, Ireland.
Statements contained in this release which are not purely historical are forward-looking statements within the meaning of the Private Securities Litigation Act of 1995 and are subject to risks and uncertainties such as those described in Merit’s Annual Report on Form 10-K for the year ended Dec. 31, 2004. Such risks and uncertainties include market acceptance of new products, introduction of products in a timely fashion, product recalls, delays in obtaining regulatory approvals, or the failure to maintain such approvals, cost increases, fluctuations in and obsolescence of inventory, price and product competition, availability of labor and materials, development of new products and technology that could render our products obsolete, product liability claims, modification or limitation of governmental or private insurance reimbursement, infringement of our technology or the assertion that our technology infringes the rights of other parties, foreign currency fluctuations, challenges associated with the company’s growth strategy, changes in health care markets related to health care reform initiatives, litigation and other factors referred to in the company’s 10-K and other reports filed with the Securities and Exchange Commission. All subsequent forward-looking statements attributable to the company or persons acting on its behalf are expressly qualified in their entirety by these cautionary statements. Actual results may differ materially from anticipated results. Financial estimates are subject to change and are not intended to be relied upon as predictions of future operating results, and Merit assumes no obligation to update or disclose revisions to those estimates.